|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.84 USD | -0.83% |
|
-7.60% | -17.19% |
| 06-17 | Top Midday Stories: Shares Decline Amid Unease Over Israel-Iran Conflict; Retail Sales Fall More Than Expected in May | MT |
| 06-17 | Trump Administration to Consider Pharma Advertising Crackdown | MT |
| Capitalization | 95.32B 83.12B 78.08B 71.01B 131B 8,279B 148B 921B 356B 3,772B 358B 350B 13,893B | P/E ratio 2025 * |
10.4x | P/E ratio 2026 * | 9.97x |
|---|---|---|---|---|---|
| Enterprise value | 128B 111B 105B 95.13B 175B 11,092B 198B 1,234B 477B 5,053B 479B 469B 18,613B | EV / Sales 2025 * |
2.77x | EV / Sales 2026 * | 2.81x |
| Free-Float |
67.93% | Yield 2025 * |
5.29% | Yield 2026 * | 5.47% |
More valuation ratios
* Estimated data
More news
Last Transcript: Bristol-Myers Squibb Company
More recommendations
More press releases
More news
| 1 day | -0.83% | ||
| 1 week | -7.60% | ||
| Current month | -2.98% | ||
| 1 month | -0.80% | ||
| 3 months | -22.04% | ||
| 6 months | -16.80% | ||
| Current year | -17.19% |
| 1 week | 46.39 |  | 49.44 |
| 1 month | 46.1 | | 50.76 |
| Current year | 44 | | 63.33 |
| 1 year | 39.35 | | 63.33 |
| 3 years | 39.35 | | 81.44 |
| 5 years | 39.35 | | 81.44 |
| 10 years | 39.35 | | 81.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 2023-10-31 | |
David Elkins
DFI | Director of Finance/CFO | 57 | 2019-11-19 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 54 | 2024-03-31 | |
Peter Arduini
BRD | Director/Board Member | 60 | 2016-03-31 |
Theodore Samuels
BRD | Director/Board Member | 70 | 2017-02-20 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 12.97% | 378 M€ | -1.30% | - | |
| 4.01% | 21 M€ | +0.39% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.83% | -7.60% | +14.78% | -36.51% | 95.32B | ||
| -0.78% | -3.33% | -11.94% | +169.86% | 705B | ||
| -1.08% | -3.79% | +3.49% | -11.05% | 363B | ||
| +1.22% | -5.93% | -50.38% | +30.75% | 331B | ||
| +0.01% | -3.60% | +8.25% | +34.14% | 328B | ||
| +0.35% | -4.62% | +4.08% | -14.29% | 254B | ||
| +0.25% | -2.92% | +1.37% | +20.55% | 228B | ||
| +0.04% | -4.33% | -14.49% | +6.33% | 220B | ||
| +1.29% | -3.09% | -38.05% | -6.30% | 199B | ||
| -0.19% | -2.62% | -5.39% | +23.34% | 156B | ||
| Average | +0.03% | -3.47% | -8.83% | +21.68% | 287.87B | |
| Weighted average by Cap. | -0.08% | -3.40% | -10.41% | +48.08% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 46.16B 40.25B 37.81B 34.39B 63.41B 4,010B 71.53B 446B 172B 1,827B 173B 170B 6,728B | 42.98B 37.48B 35.21B 32.02B 59.04B 3,733B 66.6B 415B 160B 1,701B 161B 158B 6,264B |
| Net income | 8.87B 7.73B 7.26B 6.61B 12.18B 770B 13.74B 85.69B 33.09B 351B 33.28B 32.56B 1,292B | 9.61B 8.38B 7.87B 7.16B 13.2B 834B 14.89B 92.85B 35.85B 380B 36.05B 35.28B 1,400B |
| Net Debt | 32.39B 28.24B 26.53B 24.12B 44.49B 2,813B 50.18B 313B 121B 1,281B 122B 119B 4,720B | 25.64B 22.35B 21B 19.1B 35.21B 2,227B 39.72B 248B 95.65B 1,014B 96.2B 94.15B 3,736B |
More financial data
* Estimated data
Employees
34,100
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-18 | 46.84 $ | -0.83% | 15,864,156 |
| 25-06-17 | 47.23 $ | -2.94% | 12,453,785 |
| 25-06-16 | 48.66 $ | -2.19% | 14,974,438 |
| 25-06-13 | 49.75 $ | -1.85% | 9,499,414 |
| 25-06-12 | 50.69 $ | +1.06% | 9,620,449 |
Delayed Quote Nyse, June 18, 2025 at 04:10 pm
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
27
Last Close Price
46.84USD
Average target price
57.10USD
Spread / Average Target
+21.90%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BMY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition